🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Marguerite Koutsoukos

GlaxoSmithKline (Belgium)

ORCID: 0000-0002-4174-8424

Also affiliated with GlaxoSmithKline (Switzerland)

Immunology and MicrobiologyBiochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 10 papers. Top paper: “Phase 1 Human Immunodeficiency Virus (HIV) Vaccine Trial to Evaluate the Safety and Immunogenicity of HIV Subtype C DNA and MF59-Adjuvanted Subtype C Envelope Protein”.

Phase 1 Human Immunodeficiency Virus (HIV) Vaccine Trial to Evaluate the Safety and Immunogenicity of HIV Subtype C DNA and MF59-Adjuvanted Subtype C Envelope Protein

Clinical Infectious Diseases(2020)10.1093/cid/ciz1239

N/A

1.2DataRank · unranked

35 citations

Craig Innes, Sarita Naidoo, Philipp Mann, Julia Hütter, Gita Ramjee +69 more

Safety and immune responses after a 12-month booster in healthy HIV-uninfected adults in HVTN 100 in South Africa: A randomized double-blind placebo-controlled trial of ALVAC-HIV (vCP2438) and bivalent subtype C gp120/MF59 vaccines

PLoS Medicine(2020)10.1371/journal.pmed.1003038

N/A

1.2DataRank · unranked

48 citations

Zoe Moodie, Kristen W. Cohen, Nicole Grunenberg, Linda‐Gail Bekker, Mary Allen +26 more

Analysis of the HIV Vaccine Trials Network 702 Phase 2b–3 HIV-1 Vaccine Trial in South Africa Assessing RV144 Antibody and T-Cell Correlates of HIV-1 Acquisition Risk

The Journal of Infectious Diseases(2022)10.1093/infdis/jiac260

N/A

1.1DataRank · unranked

50 citations

One Dintwe, Sheetal Sawant, Doug Grove, Yunda Huang, Holly Janes +43 more

Efficacy of a bivalent (D614 + B.1.351) SARS-CoV-2 recombinant protein vaccine with AS03 adjuvant in adults: a phase 3, parallel, randomised, modified double-blind, placebo-controlled trial

The Lancet Respiratory Medicine(2023)10.1016/s2213-2600(23)00263-1

N/A

0.750DataRank · unranked

24 citations

Nadine Rouphael, Stephen R. Walsh, Aiying Chen, Nicole Grunenberg, Mary Allen +95 more

Safety and immunogenicity of a subtype C ALVAC-HIV (vCP2438) vaccine prime plus bivalent subtype C gp120 vaccine boost adjuvanted with MF59 or alum in healthy adults without HIV (HVTN 107): A phase 1/2a randomized trial

PLoS Medicine(2024)10.1371/journal.pmed.1004360

N/A

0.439DataRank · unranked

9 citations

Erica Andersen‐Nissen, Nicole Grunenberg, One Dintwe, Faatima Laher Omar, Jia Jin Kee +29 more

Protein Dose-Sparing Effect of AS01B Adjuvant in a Randomized Preventive HIV Vaccine Trial of ALVAC-HIV (vCP2438) and Adjuvanted Bivalent Subtype C gp120

The Journal of Infectious Diseases(2023)10.1093/infdis/jiad434

N/A

0.395DataRank · unranked

7 citations

Fatima Laher, One Dintwe, Monde Muyoyeta, Allan C. deCamp, Zonglin He +27 more

Safety and immunogenicity after a 30-month boost of a subtype C ALVAC-HIV (vCP2438) vaccine prime plus bivalent subtype C gp120/MF59 vaccine boost (HVTN 100): A phase 1–2 randomized double-blind placebo-controlled trial

PLOS Global Public Health(2024)10.1371/journal.pgph.0003319

N/A

0.108DataRank · unranked

1 citations

Fatima Laher, Linda‐Gail Bekker, Kelly E. Seaton, Mary Allen, Stephen De Rosa +27 more

Early and Long-Term HIV-1 Immunogenicity Induced in Macaques by the Combined Administration of DNA, NYVAC and Env Protein-Based Vaccine Candidates: The AUP512 Study

Frontiers in Immunology(2022)10.3389/fimmu.2022.939627

N/A

0DataRank · unranked

3 citations

Benedikt Asbach, Carmen Gómez, Josef Köstler, Susan W. Barnett, Marguerite Koutsoukos +19 more

Vaccination with SARS-CoV-2 Spike Protein and AS03 Adjuvant Induces Rapid Anamnestic Antibodies in the Lung and Protects Against Virus Challenge in Nonhuman Primates

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.03.02.433390

N/A

0DataRank · unranked

36 citations

Barbara J. Flynn, Kathryn E. Foulds, Amy T. Noe, Anne P. Werner, Ian N. Moore +53 more

Protective antibodies elicited by SARS-CoV-2 spike protein vaccination are boosted in the lung after challenge in nonhuman primates

Science Translational Medicine(2021)10.1126/scitranslmed.abi4547

N/A

0DataRank · unranked

74 citations

Barbara J. Flynn, Kathryn E. Foulds, Amy T. Noe, Anne P. Werner, Ian N. Moore +55 more